Mesothelioma Latest Research

Mesothelioma Research 1

According to Science Daily, an online resource for latest research news, mesothelioma patients who got treated by a combination of 2 drugs had an improved chance of surviving. Their survival rate increased by a minimum of 3 months. The two drugs used for the treatment were PEMETREXED and CISPLATIN. The clinical trials were done on 448 mesotheliomic patients.

About 80% of the mesotheliomic patients were men with an average age of 61 years. Some patients received only cisplatin whereas some patients received a combination of pemetrexed, cisplatin, vitamin supplements, folic acid and B12. Not only did their life span increase by three months but also the patients felt less tired, had improved appetite, experienced less pain and had smaller coughing spells. The clinical trial and research was done at the Clatterbridge Center for Oncology in England.

Mesothelioma Research 2

A research published in The New England Journal of Medicine says that researchers in New York University School of Medicine and Wayne State University have discovered a molecular particle that shows the beginnings of pleural mesothelioma. The blood levels of a protein called OSTEOPONTIN rises significantly in patients with early stages of pleural mesothelioma.

This is a breakthrough discovery as it may lead to the development of a blood diagnostic test which can detect the disease pleural mesothelioma in its earliest stages. Currently the patient has to wait for mesothelioma to become a full blown case before it is properly diagnosed. Although it is incurable, the detection of pleural mesothelioma in its earliest stages, will lead to swifter treatment options with the patient having a longer survival rate and a reduced pain free life.

Mesothelioma Research 3

A study conducted by a team of researchers at University of Cincinnati have found that all those workers who used were employed at a Ohio manufacturing plant in Marysville and were exposed to vermiculite ore had abnormally high rates of chest wall lining disfigurement.

Vermiculite ore is known to contain asbestos fibers and exposure to it means that previous workers have a high chance of developing asbestosis, lung diseases and mesothelioma. Because of mesothelioma’s long latency period, researchers will not know about the development of mesothelioma in these people till the next 30-50 years.